Anderson Schock
Stock Analyst at B. Riley Securities
(0.49)
# 4,280
Out of 5,238 analysts
9
Total ratings
37.5%
Success rate
-20.13%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAT HeartBeam | Initiates: Buy | $4 | $0.89 | +349.39% | 1 | Mar 31, 2026 | |
| OPRX OptimizeRx | Reiterates: Buy | $28 → $11 | $6.44 | +70.81% | 1 | Mar 6, 2026 | |
| SPOK Spok Holdings | Downgrades: Neutral | $21 → $14 | $10.89 | +28.56% | 1 | Feb 26, 2026 | |
| MBOT Microbot Medical | Initiates: Buy | $5 | $2.13 | +134.74% | 1 | Feb 10, 2026 | |
| XGN Exagen | Reiterates: Buy | $18 → $8 | $2.95 | +171.19% | 3 | Jan 30, 2026 | |
| VREX Varex Imaging | Reiterates: Buy | $16 | $9.83 | +62.77% | 1 | Nov 19, 2025 | |
| INGN Inogen | Initiates: Buy | $14 | $7.02 | +99.43% | 1 | Jun 16, 2025 |
HeartBeam
Mar 31, 2026
Initiates: Buy
Price Target: $4
Current: $0.89
Upside: +349.39%
OptimizeRx
Mar 6, 2026
Reiterates: Buy
Price Target: $28 → $11
Current: $6.44
Upside: +70.81%
Spok Holdings
Feb 26, 2026
Downgrades: Neutral
Price Target: $21 → $14
Current: $10.89
Upside: +28.56%
Microbot Medical
Feb 10, 2026
Initiates: Buy
Price Target: $5
Current: $2.13
Upside: +134.74%
Exagen
Jan 30, 2026
Reiterates: Buy
Price Target: $18 → $8
Current: $2.95
Upside: +171.19%
Varex Imaging
Nov 19, 2025
Reiterates: Buy
Price Target: $16
Current: $9.83
Upside: +62.77%
Inogen
Jun 16, 2025
Initiates: Buy
Price Target: $14
Current: $7.02
Upside: +99.43%